Skip to main content
. Author manuscript; available in PMC: 2021 Jul 15.
Published in final edited form as: Liver Transpl. 2020 Dec 31;27(2):200–208. doi: 10.1002/lt.25936

Figure 3.

Figure 3.

Cumulative incidence of delisting due to death or clinical deterioration stratified by insurance status, with liver transplantation considered a competing event. Patients with Medicare or Medicaid were delisted due to at a more rapid rate compared to those with private insurance. At every time point following listing, a higher incidence of delisting was observed among publicly insured patients.